Enhanced CB1 Signaling Did Not Uniformly Increase Drug Reward in Mice
Mice with a desensitization-resistant CB1 receptor modestly increased consumption of dilute ethanol without showing a corresponding general increase in the tested drug-reward measures.
A genetic model, not cannabis exposure
The experiment used S426A/S430A receptor-mutant mice. It assessed voluntary ethanol drinking, conditioned place preference, acute responses and opioid dependence-related behavior. The mutation altered cannabinoid signaling; the experiment was not a comparison of human cannabis users and nonusers.
The concentration and endpoint mattered
The drinking difference appeared with the lower ethanol concentration, not uniformly across concentrations. Taste controls and selected acute-response measures did not explain it straightforwardly. Conditioned preference for the tested drugs and precipitated morphine withdrawal were not enhanced in the predicted broad fashion.
An intake signal is not an addiction diagnosis
Consumption, preference learning, acute sensitivity and dependence are related but distinct outcomes. A selective positive result cannot be converted into a global increase in addiction vulnerability. Genetic developmental effects and experimental drinking conditions further limit translation. The study supports examining specific cannabinoid-system mechanisms while rejecting a shortcut from stronger CB1 signaling to every behavioral feature of human alcohol or opioid use.
Related analysis: Cannabis Tolerance Claims: Questions to Ask Before Relying on Expert Testimony.
Primary research
Mice expressing a "hyper-sensitive" form of the CB1 cannabinoid receptor (CB1) show modestly enhanced alcohol preference and consumption. PloS one (2017). DOI: 10.1371/journal.pone.0174826.
